Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00176813
Status:
COMPLETED
Last Update Posted:
2008-05-06
First Post:
2005-09-09
Brief Title:
Gemcitabine Cisplatin and Celecoxib Treatment of Metastatic Pancreatic Cancer
Sponsor:
University of Michigan Rogel Cancer Center
Organization:
University of Michigan Rogel Cancer Center
Organization Data
Organization:
University of Michigan Rogel Cancer Center
Class:
OTHER
Study ID:
UMCC 2001-071
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Michigan Rogel Cancer Center
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
None
Responsible Party Affiliation:
None
Old Name:
Dr Mark Zalupski
Old Organization:
University of Michigan Comprehensive Cancer Center
Collaborators
| Name | Class |
|---|---|
| Barbara Ann Karmanos Cancer Institute | OTHER |
| Eli Lilly and Company | INDUSTRY |